That might not sound catastrophic, but when you are on a carefully calibrated dosing protocol , a 10 percent reduction means your 0.5 mg dose is really delivering 0.45 mg
The volume loss data (well-documented) The 2025 Vanderbilt study by Sharma and colleagues ( Otolaryngology-Head and Neck Surgery 173(2):360-366, PMID 40407186) is the strongest objective measurement of GLP-1 facial volume loss to date
Calibration and alignment were performed using 100 nm polystyrene beads (Molecular Probes)
"This is a chronic disease that needs to be treated forever," says Apovian
If you really want to stack, pick a medication that doesnt hit the same receptors as your base medication
Important safety considerations include boxed warnings for thyroid C-cell tumors (based on animal studies), and cautions regarding pancreatitis and gallbladder disease